Lilly and Merck to disclose physician payments
Executive Summary
Shortly after Lilly's Sept. 24 announcement of plans to launch an online registry of payments to doctors for speaking and consulting services, Merck says it will do the same. Both firms plan to launch their registries in 2009. The firms' announcements precede passage of the Physician Payment's Sunshine Act, legislation introduced by Sens. Chuck Grassley, R-Iowa, and Herb Kohl, D-Wis., which would mandate such disclosure. Industry's early support could help shape the legislation; PhRMA also supports a version of the legislation modified to include that requirements for the national database pre-empt state or local gift reporting requirements (1"The Pink Sheet" DAILY, May 22, 2008)
You may also be interested in...
Cephalon Must Report Payments To Physicians In Settlement Of Off-Label Charges
Cephalon is to become the third pharmaceutical company to disclose its payments to physicians. While Lilly and Merck recently volunteered to do so, Cephalon's disclosure is mandated under a settlement agreement with the U.S. Department of Justice to resolve charges that it promoted off-label use of three drugs
Grassley/Kohl Find Ray Of Sunshine From PhRMA: Group Endorses Physician Gifts Bill
Consumer groups also are “inclined to support” revised bill to establish national registry of pharma gifts to physicians.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”